Alps Medical Breakthroughs Etf Performance
| SBIO Etf | USD 30.85 0.81 2.56% |
The etf shows a Beta (market volatility) of 0.76, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ALPS Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding ALPS Medical is expected to be smaller as well.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days ALPS Medical Breakthroughs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors. ...more
| In Threey Sharp Ratio | -0.04 |
ALPS |
ALPS Medical Relative Risk vs. Return Landscape
If you would invest 3,753 in ALPS Medical Breakthroughs on November 28, 2024 and sell it today you would lose (668.00) from holding ALPS Medical Breakthroughs or give up 17.8% of portfolio value over 90 days. ALPS Medical Breakthroughs is currently does not generate positive expected returns and assumes 1.7994% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of etfs are less volatile than ALPS, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ALPS Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ALPS Medical's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as ALPS Medical Breakthroughs, and traders can use it to determine the average amount a ALPS Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1785
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SBIO |
Estimated Market Risk
| 1.8 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ALPS Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ALPS Medical by adding ALPS Medical to a well-diversified portfolio.
ALPS Medical Fundamentals Growth
ALPS Etf prices reflect investors' perceptions of the future prospects and financial health of ALPS Medical, and ALPS Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ALPS Etf performance.
| Price To Earning | 13.88 X | |||
| Price To Book | 1.80 X | |||
| Price To Sales | 4.84 X | |||
| Total Asset | 98.57 M | |||
About ALPS Medical Performance
By examining ALPS Medical's fundamental ratios, stakeholders can obtain critical insights into ALPS Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ALPS Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. Alps Medical is traded on NYSEARCA Exchange in the United States.| ALPS Medical Breakth generated a negative expected return over the last 90 days | |
| ALPS Medical Breakth created five year return of -4.0% | |
| This fund maintains 100.05% of its assets in stocks |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ALPS Medical Breakthroughs. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of ALPS Medical Breakth is measured differently than its book value, which is the value of ALPS that is recorded on the company's balance sheet. Investors also form their own opinion of ALPS Medical's value that differs from its market value or its book value, called intrinsic value, which is ALPS Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ALPS Medical's market value can be influenced by many factors that don't directly affect ALPS Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ALPS Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ALPS Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ALPS Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.